| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 166 |
| 1 | EXENATIDE | 105 |
| 2 | METFORMIN | 92 |
| 3 | METFORMIN ER 500 MG | 92 |
| 4 | METFORMIN ER 750 MG | 92 |
| 5 | LIRAGLUTIDE | 90 |
| 6 | METHOTREXATE SODIUM | 90 |
| 7 | ADALIMUMAB | 81 |
| 8 | METHOTREXATE | 77 |
| 9 | PREDNISONE | 77 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTRAN 40 | 9 | 0.1250 |
| 1 | METRELEPTIN | 6 | 0.0048 |
| 2 | BLEOMYCIN SULFATE | 23 | 0.0022 |
| 3 | EXENATIDE | 105 | 0.0020 |
| 4 | LIRAGLUTIDE | 90 | 0.0018 |
| 5 | LIOTHYRONINE SODIUM | 13 | 0.0015 |
| 6 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 4 | 0.0014 |
| 7 | MINOCYCLINE HYDROCHLORIDE | 8 | 0.0013 |
| 8 | ALEMTUZUMAB | 25 | 0.0013 |
| 9 | MINOCYCLINE | 14 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 320 |
| 1 | Corticosteroid [EPC] | 191 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 146 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 128 |
| 4 | Benzodiazepine [EPC] | 92 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 84 |
| 6 | Proton Pump Inhibitor [EPC] | 75 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 72 |
| 8 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 68 |
| 9 | Vitamin C [EPC] | 62 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Leptin Analog [EPC] | 6 | 0.0048 |
| 1 | Thyroid Stimulating Hormone [EPC] | 4 | 0.0039 |
| 2 | Plasma Volume Expander [EPC] | 9 | 0.0029 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 25 | 0.0013 |
| 5 | alpha-Glucosidase Inhibitor [EPC] | 4 | 0.0008 |
| 6 | GLP-1 Receptor Agonist [EPC] | 320 | 0.0007 |
| 7 | Nitrofuran Antibacterial [EPC] | 11 | 0.0006 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 6 | 0.0006 |
| 9 | Vitamin D3 Analog [EPC] | 12 | 0.0006 |